Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5‐Year, Retrospective, Longitudinal Study
Hirofumi Sumi, Shu Ushimaru, Kazuhiro Shiizaki, Shozo Yano, Naoto Tominaga. Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5‐Year, Retrospective, Longitudinal Study. // Therapeutic Apheresis and Dialysis. – 2026. – DOI: 10.1002/1744-9987.70185. – URL: https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70185?af=R
Hirofumi Sumi, Shu Ushimaru, Kazuhiro Shiizaki, Shozo Yano, & Naoto Tominaga (2026). Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5‐Year, Retrospective, Longitudinal Study. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70185
Hirofumi Sumi, et al. “Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5‐Year, Retrospective, Longitudinal Study.” Therapeutic Apheresis and Dialysis, 2026. doi:10.1002/1744-9987.70185.
@article{Sumi2026,
title = {Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5‐Year, Retrospective, Longitudinal Study},
author = {Sumi, Hirofumi and Ushimaru, Shu and Shiizaki, Kazuhiro and Yano, Shozo and Tominaga, Naoto},
journal = {Therapeutic Apheresis and Dialysis},
year = {2026},
doi = {10.1002/1744-9987.70185},
url = {https://onlinelibrary.wiley.com/doi/10.1002/1744-9987.70185?af=R}
}
ABSTRACT Approximately 5% of patients who develop renal rupture lack an identifiable underlying lesion, such as tumours, hydronephrosis, or vascular malformations. In this case report, we detail a case with a left renal rupture of a...
ABSTRACT Aim Both high and low body mass index (BMI) have been reported to be associated with a higher risk of chronic kidney disease (CKD) progression. However, whether this association varies across CKD stages remains unclear. We...
Nature Reviews Nephrology, Published online: 17 November 2026; doi:10.1038/s41581-026-01151-4 The concept of cardiovascular–kidney–metabolic (CKM) syndrome supports an integrated, multidisciplinary approach to improve patient outcomes....
ABSTRACT Introduction Patients on hemodialysis have an increased risk of sudden cardiac death and an increased cardiac arrhythmia burden due to large fluid and electrolyte shifts, especially during the long inter‐dialytic period....
ABSTRACT Background Therapeutic apheresis (TA) is a specialized extracorporeal blood purification modality used in the management of complex hematologic, neurologic, and autoimmune diseases. Despite established global guidelines, its...